US Patent Issued to Ajax Therapeutics on April 15 for "6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors" (New York, Oregon, New Jersey, Massachusetts Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,717, issued on April 15, was assigned to Ajax Therapeutics Inc. (New York).

"6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors" was invented by Craig E. Masse (Cambridge, Mass.), Jeremy R. Greenwood (Brooklyn, N.Y.), Sayan Mondal (New York), Jiayi Xu (Marlboro, N.J.), Phani Ghanakota (Edison, N.J.), Fiona Michelle McRobb (Brooklyn, N.Y.) and Nicholas Boyles (Hillsboro, Ore.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides 6-heteroaryloxy benzimidazole and azabenzimidazole compounds and compositions thereof useful for inhibiting JAK2."

The patent was filed on April 26, 2023, under Application No. 18...